Drug factory · FDA FEI 3002913672
Assia Chemical Industries Ltd. - Teva Tech Site
Neot Hovav Eco-Industrial Park, Be'er Sheva, Israel
Problems found, fixed voluntarily at FDA's last inspection, Sep 12, 2019.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2011: 2 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Octreotide | Makes the active ingredient | Amryt Pharmaceuticals Designated Activity Company, Chiesi USA, Inc. | 69880-120, 10122-550 |
| Risperidone | Makes the active ingredient and tests it | Indivior Inc. | 12496-0090, 12496-0120 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Sep 12, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 6, 2014 | No problems found | Drug Quality Assurance | — |
| Jun 30, 2011 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.